[28-09-am] Pharmacotherapy (Oncology)

10:46 AM - 10:58 AM JST(1:46 AM - 1:58 AM UTC)

[28-09-am10S] Chronopharmacological approach for optimization of the dose schedule of the HER2-targeted antibody drug conjugate, Trastuzumab-Deruxtecan

○Sayaka Takeda¹, Nakao Nodoka¹, Tomoaki Yamauchi¹, Mai Haraguchi¹, Yuji Omata¹, Akito Tsuruta¹, Satoru Koyanagi¹ (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)